Epithelial growth factor receptor (EGFR) is altered in ~60% of de novo GBM and ~10% of secondary GBM [55]; its most common alteration (~33% of GBM) is EGFR variant-III (EGFvIII), presenting a mutation in the extracellular portion [56]. This evidence concerns the gene EGFR and glioblastoma.